Literature DB >> 11173071

Oxygen radicals mediate the final exacerbation of endothelin-1-induced gastric ulcer in rat.

S Lazaratos1, Y Irukayama-Tomobe, T Miyauchi, K Goto, A Nakahara.   

Abstract

We investigated the role of xanthine oxidase-derived oxygen radicals in the development of endothelin-1-induced gastric ulcer. Mucosal lipid peroxidation showed a peak 24 h after injection, while gastric mucosal haemodynamics were fully restored 26 h after endothelin-1 injection. Allopurinol and oxypurinol, but not superoxide dismutase or catalase, protected the gastric mucosa 24 h after endothelin-1 injection. Oxypurinol antagonized both the vasoconstrictor effect of endothelin-1 and the decrease in gastric ATP. All treatments on the second day after endothelin-1 injection significantly reduced gastric mucosal damage. Xanthine oxidase-derived oxygen radicals contributed largely to the exacerbation but they did not mediate the onset of endothelin-1-induced gastric ulcer. Pretreatment with probucol (500 mg/kg, p.o.) also protected the gastric mucosa from endothelin-1-induced mucosal injury by its antioxidant activity. Oxypurinol was gastroprotective through its vasoactive and energy saving actions. The haemodynamic background of endothelin-1-induced gastric ulcer consists of long lasting ischaemia and subsequent "reperfusion" which may be responsible for the late burst of oxygen radicals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11173071     DOI: 10.1016/s0014-2999(01)00752-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Preventive effects of geranylgeranylacetone on rat ethanol-induced gastritis.

Authors:  Jian-Wen Ning; Guan-Bin Lin; Feng Ji; Jia Xu; Najeeb Sharify
Journal:  World J Gastroenterol       Date:  2012-05-14       Impact factor: 5.742

Review 2.  Alcoholic disease: liver and beyond.

Authors:  Alba Rocco; Debora Compare; Debora Angrisani; Marco Sanduzzi Zamparelli; Gerardo Nardone
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.